Incyte (INCY) EBT (2010 - 2026)
Incyte (INCY) recorded EBT of $751.51 million in Q2 2026, up 34.7% from $558.01 million a year earlier and up 118.7% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) EBT (2010 - 2026) Analysis & Trends
On a TTM basis, Incyte's EBT came in at $1.97 billion as of Jun 30, 2026, up 55.8% year-over-year; for FY2025, it was $1.66 billion, up 425.7% from FY2024.
- Across earlier years, EBT came in at $316.63 million in FY2024 (-62.0%), $834.22 million in FY2023 (+57.7%), $529.12 million in FY2022 (-7.2%) and $570.44 million in FY2021.
- The Q2 2026 figure is the highest quarterly EBT in data going back to Q1 2010.
- On a year-over-year basis, EBT has increased for four consecutive quarters, with growth averaging 42.2% over the last seven quarters.
- Peak year-over-year performance for EBT in the last five years was growth of 355.4% in Q1 2024, against a decline of 33.1% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $343.6 million (Q1 2026), $389.94 million (Q4 2025) and $482.31 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.39 Bn |
| 10 | Incyte | 25.09 Bn | 10.02 Bn | 1.57 Bn | 751.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 751.51 Mn |
| Mar 31, 2026 | 343.60 Mn |
| Dec 31, 2025 | 389.94 Mn |
| Sep 30, 2025 | 482.31 Mn |
| Jun 30, 2025 | 558.01 Mn |
| Mar 31, 2025 | 234.19 Mn |
| Dec 31, 2024 | 313.72 Mn |
| Sep 30, 2024 | 156.52 Mn |
| Jun 30, 2024 | -389.78 Mn |
| Mar 31, 2024 | 236.16 Mn |
| Dec 31, 2023 | 270.96 Mn |
| Sep 30, 2023 | 233.80 Mn |
| Jun 30, 2023 | 277.60 Mn |
| Mar 31, 2023 | 51.86 Mn |
| Dec 31, 2022 | 80.62 Mn |
| Sep 30, 2022 | 148.59 Mn |
| Jun 30, 2022 | 229.38 Mn |
| Mar 31, 2022 | 70.54 Mn |
| Dec 31, 2021 | 120.02 Mn |
| Sep 30, 2021 | 209.47 Mn |
API Access
Incyte EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();